Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | 47KS7 | IM / LA |
Pt mistakenly got the wrong vaccine at today's visit. Instead of the HPV that was ordered for him, he received the Bexsero that was intended for his sibling who was also present for his well check and in the room with him. This mistake was noted immediately and the family and pt were told of the incident. I have been in contact w mom and gave her the info and the data that is noted below. She will watch him for any side effects and we will continue to be in contact. We opted to hold off on the HPV until next visit. Info/data as below: Bexsero (meningococcal group B vaccine) has been studied in 12-year-old children. Clinical trials and post-licensure studies have included adolescents aged 10-25 years, which encompasses 12-year-olds, and have demonstrated immunogenicity and safety in this age group. The agency specifically recommended Bexsero for persons aged 10 years and older who are at increased risk for serogroup B meningococcal disease, and immunogenicity and safety data for this age range are presented in their guidelines. Randomized controlled trials and meta-analyses have evaluated immunogenicity and safety in children and adolescents under 18 years, including those aged 12, showing robust immune responses and an acceptable safety profile after the recommended two-dose series for adolescents. The vaccine is licensed for use in this age group in multiple countries, and real-world experience confirms finding from pre-licensure studies. The safety profile remains consistent across different populations and dosing schedules, with no evidence of increased risk in 12-year-olds compared to older adolescents. Continued pharmacovigilance supports the conclusion that Bexsero is generally safe and well tolerated in adolescents, with adverse events predominantly mild and transient. VAERS report done and will cont to communicate w family to follow for any SE. Pt. with no noted or experienced adverse side effects after the dose. Just received the dose accidentally and at age 12 yo.
None
N/A
None
None
None